Transvaginal mesh and other surgical meshes used to prevent organ perforation and pelvic organ prolapse are still being used in patients, despite warnings and known risks of severe complications. Health organizations around the world, including the Food and Drug Administration (FDA), have warned against the mesh devices.
The Accident Compensation Corporation in New Zealand has paid more than $3.1 million to nearly two thirds of the patients who have filed complaints concerning surgical and transvaginal mesh. New Zealand gynecologist Dr. Paul Macpherson said he repairs defective and botched mesh-related surgeries weekly.
Women who have received transvaginal mesh have complained of severe complications, including organ damage, internal bleeding and limited mobility. Mesh manufacturers such as Johnson & Johnson have withdrawn several devices from the market in response to growing complaints.